Rosuvastatin and running: a heart health study
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if the cholesterol-lowering drug rosuvastatin affects how your body adapts to running training. You may join if you are a long-distance runner who needs statin therapy and are willing to track your workouts with a sports watch.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and need a statin (cholesterol medicine) for your heart health.
- You run long distances at least 3 times a week and plan to keep that routine for 3 months.
- You are willing to wear a sports watch to record your training and do a treadmill stress test.
- You have no known allergy or serious side effects from statins.
- You do not have significant liver or kidney problems, leg pain, or other conditions that prevent running.
- You are not pregnant, breastfeeding, or unable to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HS-10510 in healthy people to see if it is safe and how the body handles it. It is for healthy adults who meet specific weight and cholesterol levels.
This trial tests a low dose of rosuvastatin (a common statin) in people who have had trouble with statins before. The goal is to see if your body can tolerate this specific dose again, which could help lower your cholesterol without the past side effects.
This study tests a new drug called RO7795081 to see if it changes how your body handles two common statins (pitavastatin and rosuvastatin). It is for adults who are overweight or obese but otherwise healthy, and aims to check the safety of the new drug.
This early study tests whether “liver fat” changes how a statin (rosuvastatin) works in children and teens. It may help doctors choose safer or more effective dosing in kids based on biology and a specific genetics marker.
This trial tests whether taking a statin (rosuvastatin) after a recent leg blood clot (DVT) and/or lung blood clot (PE) can lower the chance of future venous clots. You might benefit if you’re at risk for more clotting and can take the study medication safely.
This study tests how a new investigational drug, MK-4646, affects the levels of a common cholesterol medicine called rosuvastatin in healthy people. It helps researchers understand if the two drugs can be taken together safely.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.